When you’re making the move from research lab to board room, our expertise lays in uncovering the nexus between your decades of experimentation, and the practical industry outcomes waiting to be garnered from their commercial application.
We’ve served dozens of spin-outs from large hospitals and research institutions. Research teams lean on us to translate their technology into business terms.
Our hybrid model houses communications strategy and creative services under one roof. Busy executives get more in one partner, faster, and with cost efficiency.
We work directly with institutional investors in life sciences, helping firms like Rev1 Ventures support their portfolio companies with go-to-market programs.
